Erica Rivas de Srinivasa
Neurology · Austin, TXNPI 1699041772
Payments from drug & device makers
Across 135 payments — averaging $99.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$6K
- TG Therapeutics, Inc.$2K
- Amgen$2K
- EMD Serono, Inc.$1K
- Novartis$537
- Biogen$308
- plus $1K from 18 others
What the payments were for
- Consulting fees$1,69513%
- Speaking & faculty fees$1,75013%
- Grants$3,50027%
- Food & beverage$3,85730%
- Education$1671%
- Charitable contribution$2,00015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $5,530 |
| TG Therapeutics, Inc. | 11 | $2,404 |
| Amgen(2 entities) | 4 | $1,806 |
| EMD Serono, Inc. | 30 | $1,390 |
| Novartis | 21 | $537 |
| Biogen | 16 | $308 |
| AbbVie | 13 | $295 |
| Genentech USA, Inc. | 5 | $222 |
| E.r. Squibb & Sons, L.L.C. | 2 | $181 |
| Inari Medical, Inc. | 1 | $163 |
| Bristol Myers Squibb | 6 | $151 |
| ANI Pharmaceuticals, Inc. | 3 | $86 |
| AstraZeneca | 3 | $58 |
| Abbott | 3 | $54 |
| Lilly USA, LLC | 3 | $49 |
| Pfizer | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Genentech, Inc. | 1 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| GE HealthCare | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Lundbeck LLC | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Octapharma USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$1,750
- BRIUMVI$1,695
- FLOWTRIEVER CATHETER, S$326
- Mavenclad$231
- QULIPTA$109
How this compares
$13,474 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BetaseronInterferon Beta-1b | 13 | $123,997 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $9,082 |
| Primidone | 14 | $1,983 |
| Oxcarbazepine | 16 | $939 |
| Gabapentin | 32 | $494 |
| Tizanidine Hcl | 23 | $196 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $136 |
| Clonazepam | 28 | $127 |
| Ondansetron OdtOndansetron | 14 | $102 |
| Topiramate | 13 | $86 |
| Tramadol Hcl | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other neurology in Austin
- Esther MelamedAustin$593K
- Sami AboumatarAustin$593K
- Ann BassSan Antonio$12.3M
- Kandasami SenthilkumarBeaumont$7.6M
- Bharathy SundaramSherman$7.2M
- Bhupesh DiheniaLubbock$6.9M
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- Elizabeth PeckhamRound Rock$5.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.